RE: Maybe not today ;)30 Mar 2021 10:19
Levs
Not sure which way we will go after the initial excitement. Despite the RNS investors and potential investors dont know the full outcome of the phase 1 trial, start date of phase 11 trial, expected end date and results dates for phase 11, funding for phase 11, who if anyone is supporting our phase 11 trial. Thats a lot of detail that I feel it would be reasonable to have seen in the RNS this morning and that I hope is addressed this afternoon - but if it is we will then need another RNS - clumsy and feels like BoD are overwhelmed at present.
Outside Covid 19 Foralumab there are similar (mainly timeline) questions. I feel the BOD has more levers than they have hands and personally I would like to hear of either a sale of Accustem (or tils) or, significant investment in management teams so that none of their projects is hampered as they clearly are today. Staying put before you ask as I have faith in the products but financially and socially we are failing our investors and the general public as custodians of potentially transformative treatments.
Sorry - turned into a rant but probably how a lot feel today. I hope Bloomberg put GC (where I think fault lies) on the rack on these issues but usually too pally to do so.
AtB
NtD